计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| J171811-1mg |
1mg |
现货 ![]() |
| |
| J171811-5mg |
5mg |
现货 ![]() |
| |
| J171811-10mg |
10mg |
现货 ![]() |
| |
| J171811-25mg |
25mg |
现货 ![]() |
| |
| J171811-50mg |
50mg |
现货 ![]() |
| |
| J171811-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | WRB44790 | 5RV7T5BNMG | BDBM50006789 | jnj39758979 | JNJ-39758979 | GTPL8984 | JNJ-39758979, (-)- | 1046447-90-8 | (r)-4-(3-amino-pyrrolidin-1-yl)-6-isopropyl-pyrimidin-2-ylamine | Q27888282 | SCHEMBL604514 | 4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylp |
|---|---|
| 规格或纯度 | Moligand™, ≥97% |
| 英文名称 | jnj39758979 |
| 储存温度 | 2-8°C储存,避光 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | H 1 受体拮抗剂;H 2 受体拮抗剂;H 3 受体拮抗剂;H 4 受体拮抗剂 |
| 产品介绍 |
JNJ-39758979是一种选择性的、具有口服活性的、高亲和力的组胺 H4 受体 (histamine H4 receptor) 拮抗剂,对人,小鼠,猴子的组胺 H4 受体的 Ki 值分别为 12.5、5.3 和 25 nM。JNJ-39758979 对组胺诱导的 cAMP 抑制作用具有拮抗作用,pA2 为 7.9。JNJ-39758979 具有良好的抗炎、止痒作用。
JNJ-39758979 is a selective, orally active, and high-affinity histamine H4 receptor antagonist with Kis of 12.5, 5.3, and 25 nM for human, mouse, and monkey histamine H4 receptor, respectively. JNJ-39758979 functionally antagonizes histamine-induced cAMP inhibition with a pA2 of 7.9 in transfected cells. JNJ-39758979 shows good anti-inflammatory and antipruritic activity.
|
| 纯度 | ≥97% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine |
| INCHI | 1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1 |
| InChi Key | COOGVHJHSCBOQT-MRVPVSSYSA-N |
| Smiles | CC(C)C1=CC(=NC(=N1)N)N2CCC(C2)N |
| Isomeric SMILES | CC(C)C1=CC(=NC(=N1)N)N2CC[C@H](C2)N |
| 关联CAS | 1046447-90-8 |
| MeSH Entry Terms | 4-(3-aminopyrrolidin-1-yl)-6-isopropylpyrimidin-2-ylamine;JNJ 39758979 |
| 分子量 | 221.30 |
| Reaxy-Rn | 46171385 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=46171385&ln= |
| 敏感性 | 对光线敏感 |
|---|---|
| 分子量 | 221.300 g/mol |
| XLogP3 | 0.700 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 221.164 Da |
| 单同位素质量Monoisotopic Mass | 221.164 Da |
| 拓扑极表面积Topological Polar Surface Area | 81.100 Ų |
| 重原子数Heavy Atom Count | 16 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 232.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 | |
| 分析证书 | J171811 |
| 1. Savall BM, Chavez F, Tays K, Dunford PJ, Cowden JM, Hack MD, Wolin RL, Thurmond RL, Edwards JP. (2014) Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.. J Med Chem, 57 (6): (2429-39). [PMID:24495018] |
| 2. Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL. (2014) Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.. J Pharmacol Exp Ther, 349 (2): (176-84). [PMID:24549371] |
| 3. Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond RL. (2014) The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.. J Pharmacol Exp Ther, 350 (1): (181-7). [PMID:24817035] |
| 4. Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou CF, Kato T, Guzzo C et al.. (2015) Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.. J Dermatol, 42 (2): (129-39). [PMID:25491792] |